- Home
- LTRN vs GRF Comparison
LTRN vs GRF Comparison
Compare LTRN & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- GRF
- Stock Information
- Founded
- LTRN 2013
- GRF 1989
- Country
- LTRN United States
- GRF United States
- Employees
- LTRN N/A
- GRF N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- GRF Finance/Investors Services
- Sector
- LTRN Health Care
- GRF Finance
- Exchange
- LTRN Nasdaq
- GRF Nasdaq
- Market Cap
- LTRN 36.0M
- GRF 39.3M
- IPO Year
- LTRN 2020
- GRF N/A
- Fundamental
- Price
- LTRN $4.99
- GRF $10.07
- Analyst Decision
- LTRN Strong Buy
- GRF
- Analyst Count
- LTRN 1
- GRF 0
- Target Price
- LTRN $25.00
- GRF N/A
- AVG Volume (30 Days)
- LTRN 410.2K
- GRF 3.0K
- Earning Date
- LTRN 08-19-2025
- GRF 01-01-0001
- Dividend Yield
- LTRN N/A
- GRF 3.70%
- EPS Growth
- LTRN N/A
- GRF N/A
- EPS
- LTRN N/A
- GRF 1.16
- Revenue
- LTRN N/A
- GRF N/A
- Revenue This Year
- LTRN N/A
- GRF N/A
- Revenue Next Year
- LTRN N/A
- GRF N/A
- P/E Ratio
- LTRN N/A
- GRF $8.15
- Revenue Growth
- LTRN N/A
- GRF N/A
- 52 Week Low
- LTRN $2.55
- GRF $7.93
- 52 Week High
- LTRN $6.12
- GRF $10.19
- Technical
- Relative Strength Index (RSI)
- LTRN 65.68
- GRF 49.53
- Support Level
- LTRN $4.05
- GRF $9.96
- Resistance Level
- LTRN $5.74
- GRF $10.25
- Average True Range (ATR)
- LTRN 0.47
- GRF 0.15
- MACD
- LTRN 0.07
- GRF -0.03
- Stochastic Oscillator
- LTRN 62.56
- GRF 11.22
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.